Editorial Article: Advances in clinical mass spectrometry: 6 key resources for lab managers

Read this interview with Dr. Shane Tichy, Associate Vide President of R&D MS Quadrupole Instrumentation at Agilent Technologies to learn about how instrument intelligence is making clinical mass spectrometry more accessible. 
 

In this interview, Dr. Victoria Zhang, Associate Professor at the University of Rochester Medical Centre, shares her vision of enhancing clinical diagnostics and reveals how clinical mass spectrometry is helping to achieve her goals. 

Watch presentations from the 2021 Thermo Fisher Scientific LC-MS/MS virtual event on clinical mass spectrometry. Learn why LC-MS/MS is recognized as the gold standard technology for many applications, and how easy it can be to implement fully automated LC-MS/MS in a routine clinical laboratory workflow thanks to the first fully automated and regulatory compliant clinical analyzer, the Thermo Scientific™ Cascadion™ SM Clinical Analyzer.

Clinicians increasingly recognize the potential for application of dried blood spot quantification by clinical mass spectrometry and there is significant drive for the method to be incorporated into diagnostic screening workflows. In this editorial article we explore the challenges faced when incorporating dried blood spot analysis into routine diagnostics and how the RenataDX^TM Screening System has been developed to overcome them.

Related product: 
• RenataDX Screening System

Watch this presentation by Robert Wardle, Senior Scientist at Waters Corporation, titled: “I’ll Be Back” – The journey of the sample through an automated clinical mass spectrometry workflow. Understand the importance of automation, the LC-MS/MS workflows available, and the journey of a clinical patient sample through this workflow. This talk was presented at the SelectScience^® Virtual Clinical Science Summit 2021.